Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Akamai, answering, apply, applying, arm, assumed, average, banc, began, benzene, born, Brasil, cartridge, claim, comprised, cumulative, dealt, depict, en, entity, essentially, FASB, formulation, Immunocore, insignificant, Jardiance, judge, lifetime, Limelight, month, notification, officially, partner, preliminarily, preliminary, public, remanding, resubmission, retained, retrospectively, Sawai, showed, standalone, step, supplemental, vacated
Removed:
attributable, duloxetine, emerging, glucose, raloxifene, sodium
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 2 Stock Asset Purchase Agreement Between Novartis Ag and Eli Lilly and Company
- 12 Statement Re: Computation of Ratio of Earnings to Fixed Charges
- 31.1 Rule 13A-14(A) Certification of John C. Lechleiter, Chairman, President, and CEO
- 31.2 Rule 13A-14(A) Certification of Derica W. Rice, Executive Vice President, CFO
- 32 Section 1350 Certification
- Download Excel data file
- View Excel data file
Related press release
LLY similar filings
Filing view
External links